NEUROSCIENZE PHARMANESS S C A R L has a total of 17 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Italy, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are ALCASYNN PHARMACEUTICALS GMBH, NEUROSCIENZE PHARMANESS S C A and BIOTIE THERAPIES GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 4 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Foods | |
#5 | Fodder |
# | Name | Total Patents |
---|---|---|
#1 | Lazzari Paolo | 17 |
#2 | Pinna Gerard Aime | 14 |
#3 | Pani Luca | 12 |
#4 | Ruiu Stefania | 12 |
#5 | Loriga Giovanni | 11 |
#6 | Manca Ilaria | 8 |
#7 | Murineddu Gabriele | 7 |
#8 | Fadda Paolo | 2 |
#9 | Lorgia Giovanni | 1 |
#10 | Pinna Gerrard Aime | 1 |
Publication | Filing date | Title |
---|---|---|
EP2338889A1 | Diazacyclic compounds having affinity for opioid receptors | |
EP2223681A1 | Compositions of spores of non pathogenic bacteria | |
EP2149575A1 | Diazabicyclic compounds as opioid receptor agonists | |
CA2507710A1 | Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |